Porvair (LON:PRV) Hits New 1-Year High – What’s Next?

Porvair plc (LON:PRVGet Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as GBX 796 ($10.58) and last traded at GBX 772 ($10.26), with a volume of 73317 shares traded. The stock had previously closed at GBX 772 ($10.26).

Analyst Upgrades and Downgrades

Separately, Shore Capital reissued a “hold” rating on shares of Porvair in a research report on Tuesday, April 15th.

Get Our Latest Analysis on PRV

Porvair Stock Performance

The stock has a market capitalization of £353.23 million, a P/E ratio of 22.89 and a beta of 0.76. The company has a current ratio of 1.83, a quick ratio of 1.22 and a debt-to-equity ratio of 19.67. The company has a 50-day moving average price of GBX 699.26 and a 200 day moving average price of GBX 688.80.

Porvair (LON:PRVGet Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported GBX 38.60 ($0.51) EPS for the quarter. Porvair had a return on equity of 10.75% and a net margin of 8.57%. On average, research analysts forecast that Porvair plc will post 39.0358613 earnings per share for the current fiscal year.

Insider Buying and Selling at Porvair

In other news, insider Ben Stocks sold 70,000 shares of Porvair stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of GBX 716 ($9.51), for a total transaction of £501,200 ($665,958.01). 21.55% of the stock is currently owned by company insiders.

About Porvair

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications.

Featured Articles

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.